The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer

Autor: Luining, Wietske I., Hagens, Marinus J., Meijer, Dennie, Ringia, Joanneke B., de Weijer, Tessa, Bektas, Huseyyin O., Ettema, Rosemarijn H., Knol, Remco J.J., Roeleveld, Ton A., Srbljin, Sandra, Weltings, Saskia, Koppes, Jose C.C., van Moorselaar, Reindert J.A., van Leeuwen, Pim J., Oprea-Lager, Daniela E., Vis, André N.

Publikováno v: In European Urology Open Science January 2024 59:55-62

The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer.

Autor: Luining WI; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., Hagens MJ; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands.; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Meijer D; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., Ringia JB; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., de Weijer T; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Bektas HO; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Ettema RH; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., Knol RJJ; Department of Nuclear Medicine, Noordwest Hospital, Alkmaar, The Netherlands., Roeleveld TA; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands.; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department Urology, Noordwest Hospital, Alkmaar, The Netherlands., Srbljin S; Department of Nuclear Medicine, Zaans Medical Center, Zaandam, The Netherlands., Weltings S; Department of Urology, Zaans Medical Center, Zaandam, The Netherlands., Koppes JCC; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands., van Leeuwen PJ; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands.; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Prostate Cancer Network the Netherlands, Amsterdam, The Netherlands.

Publikováno v: European urology open science [Eur Urol Open Sci] 2023 Dec 22; Vol. 59, pp. 55-62. Date of Electronic Publication: 2023 Dec 22 (Print Publication: 2024).